TOPVISN | TOPVISION EYE SPECIALIST BERHAD
0.330 (0%)
T-O (am): N/A (08:59:00)
Last updated: 17:00
TOPVISN Fundamental Trend
FCON Ratio: Not enough data.
TOPVISN Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|
TOPVISN Historical Dividends
TOPVISN Financial Ratios
| EPS | 1.56 sen |
| Trailing PE (Sector Median: 25.2) | 21.1 |
| PEG | 0 |
| Altman Z | 0.0 |
| Beaver | 0 |
| Current Ratio | 0 |
| Debt-Equity (DE) Ratio | 0 |
| FCF Yield | 0.0 % |
| Revenue QoQ | 0 % |
| Revenue YoY | N/A |
| Profit QoQ | 0 % |
| Profit YoY | 0 % |
| Profit Margin (Sector Median: 9.4) | 11.23 % |
| ROE (ROIC: 0) | 0 % |
| Dividend Per Share (DPS) | 0 sen |
| Dividend Yield (DY) | 0.0 % |
TOPVISN Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 25.2) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 9.4) | |
| ROE | |
| Altman Z |
TOPVISN Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 3 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 11.23 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
TOPVISN Directors Share Purchases (Beta)
No transaction in the last 2 months.
TOPVISN Summary
Market Cap: 102 M.
Market Cap Class: Micro caps
Number of Shares: 309 M.
Adjusted Float: 0%.
TOPVISION Eye Specialist Berhad specializes in providing medical eye care services, focusing on ambulatory care for various eye diseases, including cataracts, vitreoretinal diseases, and glaucoma, through its network of 10 Ambulatory Care Centers (ACCs) across Peninsular Malaysia. Additionally, TOPVISION offers general eye health supplements through its subsidiary, TOPWELLNESS, and engages in community outreach programs such as free cataract surgeries. Its product portfolio includes implantable lenses, surgical consumables, and medications sourced from local suppliers to primarily cater to Malaysian patients. TOPVISION was incorporated in 2018 and is headquartered in Setia Alam, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0332
Website: http://www.tvesc.com/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed